EGFR and lung cancer: Optimization of the management of patients having lung cancer requires fast molecular analysis results, in particular the EGFR activating or resistance mutations analysis (http://www.e-cancer.fr/content/download/63175/568709/file/OUTTHERANOS10.pdf) [6].